Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 00133 Rome, Italy.
Neurobiol Dis. 2010 Dec;40(3):634-44. doi: 10.1016/j.nbd.2010.08.007. Epub 2010 Aug 12.
The endoplasmic reticulum (ER) stress-mediated pathway is involved in a wide range of human neurodegenerative disorders. Hence, molecules that regulate the ER stress response represent potential candidates as drug targets to tackle these diseases. In previous studies we demonstrated that upon acetylation the reticulon-1C (RTN-1C) variant of the reticulon family leads to inhibition of histone deacetylase (HDAC) enzymatic activity and endoplasmic reticulum stress-dependent apoptosis. Here, by microarray analysis of the whole human genome we found that RTN-1C is able to specifically regulate gene expression, modulating transcript clusters which have been implicated in the onset of neurodegenerative disorders. Interestingly, we show that some of the identified genes were also modulated in vivo in a brain-specific mouse model overexpressing RTN-1C. These data provide a basis for further investigation of RTN-1C as a potential molecular target for use in therapy and as a specific marker for neurological diseases.
内质网(ER)应激介导的途径涉及广泛的人类神经退行性疾病。因此,调节 ER 应激反应的分子代表了作为药物靶点来解决这些疾病的潜在候选物。在之前的研究中,我们证明了在乙酰化作用下,网质蛋白家族的 RTN-1C 变体导致组蛋白去乙酰化酶(HDAC)酶活性的抑制和内质网应激依赖性凋亡。在这里,通过对整个人类基因组的微阵列分析,我们发现 RTN-1C 能够特异性地调节基因表达,调节与神经退行性疾病发病有关的转录簇。有趣的是,我们表明,在过表达 RTN-1C 的大脑特异性小鼠模型中,一些鉴定出的基因也在体内被调节。这些数据为进一步研究 RTN-1C 作为治疗的潜在分子靶标以及作为神经疾病的特异性标志物提供了基础。